FDA Inspection 1341414 — LOTTE Biologics USA, LLC
The FDA completed an inspection of LOTTE Biologics USA, LLC on Sep 18, 2026 in East Syracuse, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 18, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- East Syracuse, NY (United States)